Germany · Delayed Price · Currency is EUR Ypsomed Holding AG Company Description
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication companies.
The company operates through three segments: Ypsomed Delivery Systems, Ypsomed Diabetes Care, and Others.
The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto-injectors, and wearable injectors, as well as other smart devices.
This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insulin pumps, infusion sets, pen needles, blood glucose monitoring systems, accessories, and other day-to-day items for diabetics.
This segment offers its products under the mylife brand name. The company offers precision turned parts; and contract manufacturing and other services.
It markets its products through pharmaceutical partners, as well as through its own distribution network and independent distributors.
It operates in Switzerland, Europe, North America, and internationally. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland.
| Country | Switzerland |
| Founded | 1984 |
| Industry | Orthopedic, Prosthetic, and Surgical Appliances and Supplies |
| Employees | 2,644 |
| CEO | Simon Michel |
Contact Details
Address: Brunnmattstrasse 6 Burgdorf, 3401 Switzerland | |
| Phone | 41 34 424 41 11 |
| Website | ypsomed.com |
Stock Details
| Ticker Symbol | OWX |
| Exchange | Frankfurt Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | CHF |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Simon Michel | Chief Executive Officer |
| Samuel Kunzli | Chief Financial Officer |
| Frank Mengis | Chief Operating Officer |
| Sam Ghezelbash | Head of Investor Relations |